BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20103644)

  • 1. Lung metastasis fails in MMTV-PyMT oncomice lacking S100A4 due to a T-cell deficiency in primary tumors.
    Grum-Schwensen B; Klingelhöfer J; Grigorian M; Almholt K; Nielsen BS; Lukanidin E; Ambartsumian N
    Cancer Res; 2010 Feb; 70(3):936-47. PubMed ID: 20103644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100A4-neutralizing antibody suppresses spontaneous tumor progression, pre-metastatic niche formation and alters T-cell polarization balance.
    Grum-Schwensen B; Klingelhöfer J; Beck M; Bonefeld CM; Hamerlik P; Guldberg P; Grigorian M; Lukanidin E; Ambartsumian N
    BMC Cancer; 2015 Feb; 15():44. PubMed ID: 25884510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of tumor development and metastasis formation in mice lacking the S100A4(mts1) gene.
    Grum-Schwensen B; Klingelhofer J; Berg CH; El-Naaman C; Grigorian M; Lukanidin E; Ambartsumian N
    Cancer Res; 2005 May; 65(9):3772-80. PubMed ID: 15867373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the calcium-binding protein S100A4 (p9Ka) in MMTV-neu transgenic mice induces metastasis of mammary tumours.
    Davies MP; Rudland PS; Robertson L; Parry EW; Jolicoeur P; Barraclough R
    Oncogene; 1996 Oct; 13(8):1631-7. PubMed ID: 8895508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100a4 upregulation in Pik3caH1047R;Trp53R270H;MMTV-Cre-driven mammary tumors promotes metastasis.
    Yuan W; Goldstein LD; Durinck S; Chen YJ; Nguyen TT; Kljavin NM; Sokol ES; Stawiski EW; Haley B; Ziai J; Modrusan Z; Seshagiri S
    Breast Cancer Res; 2019 Dec; 21(1):152. PubMed ID: 31881983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromally derived lysyl oxidase promotes metastasis of transforming growth factor-β-deficient mouse mammary carcinomas.
    Pickup MW; Laklai H; Acerbi I; Owens P; Gorska AE; Chytil A; Aakre M; Weaver VM; Moses HL
    Cancer Res; 2013 Sep; 73(17):5336-46. PubMed ID: 23856251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-derived mesenchymal stem cells and orthotopic site increase the tumor initiation potential of putative mouse mammary cancer stem cells derived from MMTV-PyMT mice.
    Lanza DG; Ma J; Guest I; Uk-Lim C; Glinskii A; Glinsky G; Sell S
    Tumour Biol; 2012 Dec; 33(6):1997-2005. PubMed ID: 22836804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pleiotropic functions of the tumor- and metastasis-suppressing matrix metalloproteinase-8 in mammary cancer in MMTV-PyMT transgenic mice.
    Decock J; Hendrickx W; Thirkettle S; Gutiérrez-Fernández A; Robinson SD; Edwards DR
    Breast Cancer Res; 2015 Mar; 17(1):38. PubMed ID: 25848906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of tumour histopathology and gene expression in a neu/S100A4 transgenic model of metastatic breast cancer.
    Simpson PT; Shoker BS; Barraclough R; Halliwell N; Rudland PS; Sibson DR; Davies MP
    Int J Exp Pathol; 2003 Aug; 84(4):173-84. PubMed ID: 14632631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-S100A4 antibody suppresses metastasis formation by blocking stroma cell invasion.
    Klingelhöfer J; Grum-Schwensen B; Beck MK; Knudsen RS; Grigorian M; Lukanidin E; Ambartsumian N
    Neoplasia; 2012 Dec; 14(12):1260-8. PubMed ID: 23308057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization.
    O'Connell JT; Sugimoto H; Cooke VG; MacDonald BA; Mehta AI; LeBleu VS; Dewar R; Rocha RM; Brentani RR; Resnick MB; Neilson EG; Zeisberg M; Kalluri R
    Proc Natl Acad Sci U S A; 2011 Sep; 108(38):16002-7. PubMed ID: 21911392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis-inducing S100A4 and RANTES cooperate in promoting tumor progression in mice.
    Forst B; Hansen MT; Klingelhöfer J; Møller HD; Nielsen GH; Grum-Schwensen B; Ambartsumian N; Lukanidin E; Grigorian M
    PLoS One; 2010 Apr; 5(4):e10374. PubMed ID: 20442771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor ligands as new extracellular targets for the metastasis-promoting S100A4 protein.
    Klingelhöfer J; Møller HD; Sumer EU; Berg CH; Poulsen M; Kiryushko D; Soroka V; Ambartsumian N; Grigorian M; Lukanidin EM
    FEBS J; 2009 Oct; 276(20):5936-48. PubMed ID: 19740107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ADAMTS1 protease gene is required for mammary tumor growth and metastasis.
    Ricciardelli C; Frewin KM; Tan Ide A; Williams ED; Opeskin K; Pritchard MA; Ingman WV; Russell DL
    Am J Pathol; 2011 Dec; 179(6):3075-85. PubMed ID: 22001177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of mammary cancer stem cells in the MMTV-PyMT mouse model.
    Ma J; Lanza DG; Guest I; Uk-Lim C; Glinskii A; Glinsky G; Sell S
    Tumour Biol; 2012 Dec; 33(6):1983-96. PubMed ID: 22878936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo. Role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretion.
    Williams TM; Medina F; Badano I; Hazan RB; Hutchinson J; Muller WJ; Chopra NG; Scherer PE; Pestell RG; Lisanti MP
    J Biol Chem; 2004 Dec; 279(49):51630-46. PubMed ID: 15355971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The E2F transcription factors regulate tumor development and metastasis in a mouse model of metastatic breast cancer.
    Hollern DP; Honeysett J; Cardiff RD; Andrechek ER
    Mol Cell Biol; 2014 Sep; 34(17):3229-43. PubMed ID: 24934442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomarkers of residual disease, disseminated tumor cells, and metastases in the MMTV-PyMT breast cancer model.
    Franci C; Zhou J; Jiang Z; Modrusan Z; Good Z; Jackson E; Kouros-Mehr H
    PLoS One; 2013; 8(3):e58183. PubMed ID: 23520493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metastasis is strongly reduced by the matrix metalloproteinase inhibitor Galardin in the MMTV-PymT transgenic breast cancer model.
    Almholt K; Juncker-Jensen A; Laerum OD; Danø K; Johnsen M; Lund LR; Rømer J
    Mol Cancer Ther; 2008 Sep; 7(9):2758-67. PubMed ID: 18790756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic potential of B16-F10 melanoma cells is enhanced by extracellular S100A4 derived from RAW264.7 macrophages.
    Haase-Kohn C; Wolf S; Herwig N; Mosch B; Pietzsch J
    Biochem Biophys Res Commun; 2014 Mar; 446(1):143-8. PubMed ID: 24613382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.